Publications by authors named "N A Sher"

Mitochondrial DNA (mtDNA) quantification is crucial in understanding mitochondrial dysfunction, which is linked to a variety of diseases, including cancer and neurodegenerative disorders. Traditional methods often rely on amplification-based techniques, which can introduce bias and lack the precision needed for clinical diagnostics. Solid-state nanopores, an emerging biosensing platform, have the advantage of offering single-molecule and label-free approaches by enabling the direct counting of DNA molecules without amplification.

View Article and Find Full Text PDF

Diabetes mellitus (DM) is a non-communicable, life-threatening syndrome prevalent worldwide. One effective treatment for DM is the medicinal use of green synthesized silver nanoparticles (AgNPs), which are eco-friendly and cost-effective. This study investigates the antidiabetic potential of greensynthesizedAgNPs derived from a polyherbal formulation (PHF).

View Article and Find Full Text PDF

Objectives: Hemophagocytic lymphohistiocytosis (HLH) is a rare disorder of hypercytokinemia and immune dysregulation. Most commonly diagnosed in the pediatric population due to genetic predisposition, the condition can manifest in the adult population secondary to an immune dysregulating event, such as infection, malignancy, rheumatologic disorders, immunodeficiency, and checkpoint inhibitors. The presentation and diagnosis during pregnancy are extremely rare and elusive.

View Article and Find Full Text PDF

Green synthesis of nanoparticles (NPs) is preferred for its affordability and environmentally friendly approach. This study explored the synthesis and characterization of silver NPs (AgNPs) and examined their impact on the growth of Zea mays, both alone and in combination with nickel chloride (NiCl). A methanolic leaf extract was combined with silver nitrate to synthesize AgNPs.

View Article and Find Full Text PDF
Article Synopsis
  • Tight glycemic control is crucial after CABG surgery, and this study investigates the impact of early versus delayed transition from IV to subcutaneous insulin on patient outcomes.
  • Researchers analyzed data from 394 patients, splitting them into early (postoperative day 1) and delayed transition groups, to assess euglycemia rates and other variables.
  • Results showed that early transition led to shorter ICU and hospital stays without increasing the need to restart IV insulin, highlighting its benefits for post-surgery recovery.
View Article and Find Full Text PDF